Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.

Capital will fuel continued research and clinical development of micro-infusion platform EMERYVILLE, Calif., June 21, 2018 -- (Healthcare Sales & Marketing Network) -- Mercator MedSystems, Inc., today announced it has received $11 million in Series D e... Devices, Interventional, Venture Capital Mercator MedSystems, Shenzhen Salubris Pharmaceuticals, Bullfrog, Micro-Infusion
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news